Westport Asset Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Westport Asset Management’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-10,000	Closed	-$7K	–	76
2021 Q1	$7K	Hold	10,000	–	–	﹤0.01%	74
2020 Q4	$7K	Hold	10,000	–	–	﹤0.01%	71
2020 Q3	$23K	Hold	10,000	–	–	0.01%	71
2020 Q2	$36K	Hold	10,000	–	–	0.02%	69
2020 Q1	$38K	Hold	10,000	–	–	0.03%	66
2019 Q4	$30K	Buy	+10,000	New	+$26K	0.02%	61

Other funds holding BMY.RT

JCI

Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Westport Asset Management's BMY.RT Position: Q2 2021 in Review

Westport Asset Management sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q2 2021, closing a stake of 10,000 shares — an estimated $7K sold.

Westport Asset Management first reported a position in BMY.RT in Q4 2019 and held it in 6 quarters. The position peaked at $38K in Q1 2020. 8 funds tracked by Wall St. Rank hold BMY.RT as of Q2 2021.

Westport Asset Management reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q2 2021 after selling out during the quarter.
Westport Asset Management sold 10,000 Bristol-Myers Squibb Company Contingent Value Rights shares in Q2 2021, an estimated $7K.
Westport Asset Management first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 6 quarters.
Westport Asset Management's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $38K in Q1 2020.
8 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q2 2021.

Based on Westport Asset Management's 13F filing for Q2 2021, filed 11 Aug 2021.